Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 6,200 shares at $20.01 ($124K) on 2023-06-08, disclosed to the SEC on 2023-06-12.
Scheduled sale ($124k) by President/CEO and Board Chair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.01 | 3,100 | $62K | 50.0% |
| 2 | $20.01 | 3,100 | $62K | 50.0% |
| Total | $20.01 avg | 6,200 | $124K | 100% |
| Filing → |
| TARS | SELL | 2026-06-22 | $615K | — | Filing → |
| TARS | SELL | 2026-03-19 | $2.4M | — | Filing → |
| TARS | SELL | 2025-12-30 | $944K | — | Filing → |